XML 1025 R76.htm IDEA: XBRL DOCUMENT v2.4.0.8
WARRANTS (Details) (USD $)
In Millions, unless otherwise specified
1 Months Ended 12 Months Ended
Mar. 31, 2010
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Warrants issued exercisable for BioScrip common stock 3.4  
Term of warrants   5 years
Exercise price of warrants 10.00 10
Percentage below fair value of common stock issued, triggering increase in shares issued upon exercise of warrants (less than 90%)   90.00%
Warrants outstanding   3.4
Fair value of warrants outstanding   $ 12.3
Expected volatility   62.00%
Risk-free interest rate   2.63%
Dividend rate   0.00%
Expected life of options   5 years
Discount applied for lack of marketability   13.50%